PANTHERx®Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)
April 01, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Selected by Chiesi Global Rare Diseases for the Distribution of Filsuvez® (birch triterpenes) topical gel
February 07, 2024
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States,...
Read More
PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 07, 2023
PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual
MMIT Patient Choice Award, once again, has...
Read More
PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO®(rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)
August 02, 2023
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
PANTHERx Rare Announces Exciting Leadership Changes: New President and Key Hire
June 20, 2023
PITTSBURGH, June 21, 2023 /PRNewswire/ — PANTHERx Rare, the
nation’s leading rare disease pharmacy, is excited...
Read More
PANTHERx Rare Pharmacy Expands Services to Include Dispensing AYVAKIT® (avapritinib) for the Expanded Approval for Treatment of Indolent Systemic Mastocytosis (ISM).
June 19, 2023
Blueprint Medicines recently announced the approval of AYVAKIT® (avapritinib)
for...
Read More
